Poste G, Tzeng J, Doll J, Greig R, Rieman D, Zeidman I
Proc Natl Acad Sci U S A. 1982 Nov;79(21):6574-8. doi: 10.1073/pnas.79.21.6574.
The metastatic properties of tumor cell clones isolated from individual lesions of B16 melanoma metastatic to lung have been examined at different stages in the evolution of metastasis. Clonal analysis of metastatic lesions produced by B16 melanoma populations containing clones with identifiable, stable drug-resistance markers revealed that the majority (greater than 80%) of experimental metastases produced by intravenous injection of tumor cells are of unicellular origin. During the early stages of their growth (less than 25 days after initial tumor cell arrest), the majority of metastatic lesions contain cells with indistinguishable metastatic phenotypes (intralesional clonal homogeneity) although different clonally homogeneous lesions from the same host contain tumor cells with different metastatic phenotypes (interlesional clonal heterogeneity). Progressive growth of metastatic lesions is accompanied by emergence, within originally clonally homogeneous lesions, of variant tumor cells with altered metastatic properties (intralesional clonal heterogeneity). By 40-45 days after initial arrest of injected tumor cells in the lung, 90% of the metastatic lesions are populated by cells with heterogeneous metastatic phenotypes.
对从转移至肺部的B16黑色素瘤的单个病灶中分离出的肿瘤细胞克隆的转移特性,在转移演变的不同阶段进行了研究。对含有具有可识别的、稳定耐药标记的克隆的B16黑色素瘤群体产生的转移病灶进行克隆分析,结果显示,通过静脉注射肿瘤细胞产生的大多数(超过80%)实验性转移灶起源于单细胞。在其生长的早期阶段(初始肿瘤细胞停滞后不到25天),大多数转移病灶含有具有难以区分的转移表型的细胞(病灶内克隆同质性),尽管来自同一宿主的不同克隆同质性病灶含有具有不同转移表型的肿瘤细胞(病灶间克隆异质性)。转移病灶的渐进性生长伴随着在原本克隆同质性病灶内出现具有改变的转移特性的变异肿瘤细胞(病灶内克隆异质性)。在注射的肿瘤细胞在肺部初始停滞40 - 45天后,90%的转移病灶由具有异质转移表型的细胞构成。